HOME >> BIOLOGY >> NEWS
J&JPRD discovery may lead to new treatments for chronic sensitivity, pain caused by cold

Raritan, NJ (May 2, 2007) -- Researchers at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that they have discovered a biological basis for explaining how people sense cold temperatures.

Ultimately, these findings may be a critical step in developing treatments for patients who suffer from hypersensitivity to cold, such as occurs in neuropathic pain and complex regional pain syndromes. This research is published in the May 3, 2007 issue of Neuron.

In the study, researchers sought to understand the mechanisms underlying cold sensitivity. Scientists used a line of mice that lacked a critical ion channel receptor called TRPM8, also referred to as the cold menthol receptor 1. Then, they tested how these mice reacted to cold stimuli, and found that not having these receptors reduced their adverse reactions to the cold, both under normal and pathological conditions. Results suggest that TRPM8 modulation could play an important role in certain types of cold-induced pain in humans and could hold therapeutic potential in the treatment of many chronic, painful conditions for which there are currently limited effective treatment options.

"This work represents the culmination of a multi-year collaborative effort on the part of J&JPRD scientists to help explain fundamental mechanisms involved in human pain states and may lead to the development of innovative medicines to relieve patient suffering," said Christopher Flores, Ph.D., Biology Team Leader for Analgesics, J&JPRD. "Although preliminary, these findings provide compelling initial evidence toward validating TRPM8 as an analgesic drug target and addressing major unmet medical needs of pain patients."

Ion channels are proteins that form tiny openings through the membrane of a cell and allow the passage of certain ions that regulate cellular activities. Some of these channels are opened by chemicals, some by changes in voltage and othe
'"/>

Contact: Lisa Vaga
lvaga@prdus.jnj.com
908-218-7316
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2-May-2007


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. New proteomics research promises to revolutionize biomedical discovery
3. MU researchers make discovery in molecular mechanics of phototropism
4. International team to honor 30th anniversary of deep-sea vent discovery in Galpagos
5. Screening approach leads to discovery of gene linked to breast cancer
6. Lucky 13 as new gene discovery offers further hope for childhood blindness
7. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
8. Biting discovery: MU entomologist finds host of new aquatic insect species in Thailand
9. Protein enables discovery of quantum effect in photosynthesis
10. Unicellular microRNA discovery
11. Jefferson researchers discovery may change thinking on how viruses invade the brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology:
Cached News: